ARK Investment Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-93,143
| Closed | -$2.08M | – | 208 |
|
|
2018
Q1 | $2.08M | Buy |
93,143
+39,967
| +75% | +$893K | 0.1% | 83 |
|
|
2017
Q4 | $678K | Buy |
53,176
+24,644
| +86% | +$314K | 0.05% | 109 |
|
|
2017
Q3 | $445K | Buy |
28,532
+16,600
| +139% | +$259K | 0.05% | 116 |
|
|
2017
Q2 | $167K | Buy |
11,932
+10,121
| +559% | +$142K | 0.03% | 99 |
|
|
2017
Q1 | $40K | Buy |
+1,811
| New | +$40K | 0.01% | 96 |
|